Analyst Recommendations

Raymond James analyst issues OUTPERFORM recommendation for WBD on October 2, 2025 10:40AM ET. The previous analyst recommendation was Outperform.WBD was trading at $19.35 at issue of the...

October 2, 2025   WBD -0.83%

Barclays analyst issues OVERWEIGHT recommendation for CERT on October 2, 2025 10:42AM ET. The previous analyst recommendation was Overweight.CERT was trading at $13.37 at issue of the analyst...

October 2, 2025   CERT -3.00%

Barclays analyst issues OVERWEIGHT recommendation for EXAS on October 2, 2025 10:42AM ET. The previous analyst recommendation was Overweight.EXAS was trading at $56.43 at issue of the analyst...

October 2, 2025   EXAS -0.09%

Barclays analyst issues OVERWEIGHT recommendation for AVTR on October 2, 2025 10:41AM ET. The previous analyst recommendation was Overweight.AVTR was trading at $13.67 at issue of the analyst...

October 2, 2025   AVTR -0.21%

Barclays analyst issues OVERWEIGHT recommendation for GH on October 2, 2025 10:42AM ET. The previous analyst recommendation was Overweight.GH was trading at $62.65 at issue of the analyst...

October 2, 2025   GH -3.30%

Barclays analyst issues UNDERWEIGHT recommendation for FTRE on October 2, 2025 10:42AM ET. The previous analyst recommendation was Underweight.FTRE was trading at $9.52 at issue of the analyst...

October 2, 2025   FTRE -2.28%

RBC Capital analyst issues OUTPERFORM recommendation for IFSPF on October 2, 2025 10:37AM ET. The previous analyst recommendation was Outperform.IFSPF was trading at $7.26 at issue of the...

October 2, 2025   IFSPF -5.13%

Barclays analyst issues UNDERWEIGHT recommendation for ILMN on October 2, 2025 10:42AM ET. The previous analyst recommendation was Underweight.ILMN was trading at $102.26 at issue of the analyst...

October 2, 2025   ILMN -2.00%

Barclays analyst issues OVERWEIGHT recommendation for TMO on October 2, 2025 10:44AM ET. The previous analyst recommendation was Overweight.TMO was trading at $530.73 at issue of the analyst...

October 2, 2025   TMO -1.12%

Barclays analyst issues OVERWEIGHT recommendation for QGEN on October 2, 2025 10:43AM ET. The previous analyst recommendation was Overweight.QGEN was trading at $46.32 at issue of the analyst...

October 2, 2025   QGEN -0.96%